Evoxac and Levothyroxine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Evoxac and Levothyroxine sodium. Common interactions include fatigue among females and body height decreased among males.

The phase IV clinical study analyzes what interactions people who take Evoxac and Levothyroxine sodium have. It is created by eHealthMe based on reports of 45 people who take Evoxac and Levothyroxine sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 19, 2022

45 people who take Evoxac and Levothyroxine sodium together, and have interactions are studied.


What is Evoxac?

Evoxac has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 1,816 Evoxac users for its effectiveness, alternative drugs and more.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 102,986 Levothyroxine sodium users for its effectiveness, alternative drugs and more.

Number of Evoxac and Levothyroxine sodium reports submitted per year:

Evoxac and Levothyroxine sodium drug interactions.

Common Evoxac and Levothyroxine Sodium drug interactions by gender *:

female:

  1. Fatigue
  2. Pneumocystis carinii pneumonia
  3. Hypertension
  4. Pain in extremity
  5. Actinic keratosis
  6. Anaemia
  7. Arthropathy
  8. Device failure
  9. Dyspnoea
  10. Femur fracture

male:

  1. Body height decreased
  2. Bronchitis
  3. Haemoglobin decreased
  4. Influenza
  5. Labyrinthitis
  6. Myelodysplastic syndrome
  7. Organising pneumonia
  8. Pneumonia
  9. White blood cell count decreased

Common Evoxac and Levothyroxine Sodium drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arthralgia
  2. Erythema
  3. Fall
  4. Infection
  5. Injection site nodule
  6. Injection site pain
  7. Joint swelling
  8. Laceration
  9. Rash

50-59:

  1. Tachycardia
  2. Blood culture positive
  3. Dyspnoea
  4. Empyema
  5. Laryngeal oedema
  6. Pleuritic pain
  7. Pulmonary embolism
  8. Stridor
  9. Suicidal ideation
  10. Agitation

60+:

  1. Pain in extremity
  2. Actinic keratosis
  3. Lower gastrointestinal haemorrhage
  4. Major depression
  5. Muscle spasms
  6. Type 2 diabetes mellitus
  7. Venous insufficiency
  8. Thrombocytopenia
  9. Transient ischaemic attack
  10. Upper limb fracture

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 17.78%
  2. Osteopenia (a condition where bone mineral density is lower than normal): 5 people, 11.11%
  3. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 8.89%
  4. Osteoporosis (bones weak and more likely to break): 4 people, 8.89%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 8.89%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 8.89%
  7. Tardive Dyskinesia (a disorder that involves involuntary movements): 3 people, 6.67%
  8. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Evoxac and Levothyroxine sodium?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Evoxac and Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Evoxac interactions:

Browse all interactions between Evoxac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levothyroxine sodium interactions:

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cevimeline hydrochloride and levothyroxine sodium (the active ingredients of Evoxac and Levothyroxine sodium, respectively), and Evoxac and Levothyroxine sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: